Patient-reported Outcomes And Health-care Resource Utilization In Patients With Psoriasis Treated With Etanercept: Continuous Versus Interrupted Treatment

Title

Patient-reported Outcomes And Health-care Resource Utilization In Patients With Psoriasis Treated With Etanercept: Continuous Versus Interrupted Treatment

Creator

Gelfand J M; Kimball A B; Mostow E N; Chiou C F; Patel V; Xia H A; Freundlich B; Stevens S R

Publisher

Value in Health

Date

2008
2008-05

Subject

arthritis; atopic-dermatitis; Business & Economics; clinical trial; depression; double-blind; efficacy; etanercept; Health Care Sciences & Services; health-care resource utilization; monotherapy; phase-iii trial; plaque psoriasis; psoriasis; quality-of-life; quality-of-life; therapy; tumor necrosis factor

Format

Journal Article or Conference Abstract Publication

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

400-407

Issue

3

Volume

11

Citation

Gelfand J M; Kimball A B; Mostow E N; Chiou C F; Patel V; Xia H A; Freundlich B; Stevens S R, “Patient-reported Outcomes And Health-care Resource Utilization In Patients With Psoriasis Treated With Etanercept: Continuous Versus Interrupted Treatment,” NEOMED Bibliography Database, accessed December 2, 2021, https://neomed.omeka.net/items/show/9681.

Social Bookmarking